Taysha Gene Therapies
TSHA
TSHA
62 hedge funds and large institutions have $411M invested in Taysha Gene Therapies in 2023 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
+23
Holders Change %
+58.97%
% of All Funds
0.99%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
34
Increased
14
Reduced
6
Closed
11
Calls
$785K
Puts
$663K
Net Calls
+$122K
Net Calls Change
+$127K
Top Buyers
1 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
$77.5M |
2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
$58.4M |
3 |
RI
RTW Investments
New York
|
$53.4M |
4 |
VA
VR Adviser
New York
|
$45.6M |
5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
$35.1M |